Piscataway, NJ, September 25, 2014– Camber Pharmaceuticals announced Thursday that it has launched Raloxifene Hydrochloride, USP 60 mg tablets. The drug is the generic version of Evista® tablets.
Raloxifene is available in 30 and 100 count bottles.
“Raloxifene is an important product addition in Camber’s portfolio, one of many we have planned in the coming months” said Kon Ostaficiuk, president of Camber. “Our continued growth as a leading generic supplier is a testament to our strong API manufacturing and the integrity of our supply chain.”
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
